These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19269133)

  • 1. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.
    Jassal DS; Han SY; Hans C; Sharma A; Fang T; Ahmadie R; Lytwyn M; Walker JR; Bhalla RS; Czarnecki A; Moussa T; Singal PK
    J Am Soc Echocardiogr; 2009 Apr; 22(4):418-24. PubMed ID: 19269133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of myocardial dysfunction during cancer chemotherapy with tissue Doppler imaging: a canary in the coal mine?
    Hoit BD
    J Am Soc Echocardiogr; 2009 Apr; 22(4):425-6. PubMed ID: 19345310
    [No Abstract]   [Full Text] [Related]  

  • 3. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
    Fallah-Rad N; Walker JR; Wassef A; Lytwyn M; Bohonis S; Fang T; Tian G; Kirkpatrick ID; Singal PK; Krahn M; Grenier D; Jassal DS
    J Am Coll Cardiol; 2011 May; 57(22):2263-70. PubMed ID: 21616287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.
    Negishi K; Negishi T; Haluska BA; Hare JL; Plana JC; Marwick TH
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):324-31. PubMed ID: 24057661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
    Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
    Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury.
    Neilan TG; Jassal DS; Perez-Sanz TM; Raher MJ; Pradhan AD; Buys ES; Ichinose F; Bayne DB; Halpern EF; Weyman AE; Derumeaux G; Bloch KD; Picard MH; Scherrer-Crosbie M
    Eur Heart J; 2006 Aug; 27(15):1868-75. PubMed ID: 16717080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography.
    Emren SV; Tuluce SY; Levent F; Tuluce K; Kalkan T; Yildiz Y; Alacacioğlu A; Kucukzeybek Y; Akyol M; Salman T
    Med Ultrason; 2015 Dec; 17(4):496-502. PubMed ID: 26649345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular endocardial dysfunction in patients with preserved ejection fraction after receiving anthracycline.
    Miyoshi T; Tanaka H; Kaneko A; Tatsumi K; Matsumoto K; Minami H; Kawai H; Hirata K
    Echocardiography; 2014 Aug; 31(7):848-57. PubMed ID: 24354985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.
    Hare JL; Brown JK; Leano R; Jenkins C; Woodward N; Marwick TH
    Am Heart J; 2009 Aug; 158(2):294-301. PubMed ID: 19619708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies.
    Rayson D; Richel D; Chia S; Jackisch C; van der Vegt S; Suter T
    Ann Oncol; 2008 Sep; 19(9):1530-9. PubMed ID: 18480068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy.
    Yu AF; Ho AY; Braunstein LZ; Thor ME; Lee Chuy K; Eaton A; Mara E; Cahlon O; Dang CT; Oeffinger KC; Steingart RM; Liu JE
    J Am Soc Echocardiogr; 2019 Apr; 32(4):521-528. PubMed ID: 30826225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
    Chia S; Clemons M; Martin LA; Rodgers A; Gelmon K; Pond GR; Panasci L
    J Clin Oncol; 2006 Jun; 24(18):2773-8. PubMed ID: 16682726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
    Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
    J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
    Andreopoulou E; Gaiotti D; Kim E; Volm M; Oratz R; Freedberg R; Downey A; Vogel CL; Chia S; Muggia F
    Clin Breast Cancer; 2007 Aug; 7(9):690-6. PubMed ID: 17919349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
    Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Cohen V; Gosavi S; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
    Am J Cardiol; 2011 May; 107(9):1375-80. PubMed ID: 21371685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
    Batist G; Harris L; Azarnia N; Lee LW; Daza-Ramirez P
    Anticancer Drugs; 2006 Jun; 17(5):587-95. PubMed ID: 16702817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy.
    Upshaw JN; Finkelman B; Hubbard RA; Smith AM; Narayan HK; Arndt L; Domchek S; DeMichele A; Fox K; Shah P; Clark A; Bradbury A; Matro J; Adusumalli S; Carver JR; Ky B
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 2):198-210. PubMed ID: 31542526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.